Celularity (CELU) FCF Margin Growth (3y) (2023 - 2025)
Celularity (CELU) FCF Margin Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | -3,088.00 |
| 10 | Celularity | 19.68 Mn | 13.50 Mn | -3.27 Mn | 61,104.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50,077.00 |
| Sep 30, 2025 | 87,130.00 |
| Jun 30, 2025 | 99,416.00 |
| Mar 31, 2025 | 56,804.00 |
| Dec 31, 2024 | 62,137.00 |
| Sep 30, 2024 | 36,029.00 |
| Jun 30, 2024 | 53,946.00 |
| Mar 31, 2024 | 92,339.00 |
| Dec 31, 2023 | 76,736.00 |
| Sep 30, 2023 | 115,331.00 |